Clinical trial
Prevention of Contrast-Induced Nephropathy
NCT00175227 · University of Alberta, Other · Completed
Key facts
| NCT number | NCT00175227 |
|---|---|
| Title | Prevention of Contrast-Induced Nephropathy |
| Official title | Prevention of Contrast-Induced Nephropathy: a Randomized Controlled Trial of Saline + Furosemide + Mannitol in High Risk Patients Undergoing Cardiac Angiography |
| Lead sponsor | University of Alberta, Other |
| Collaborators | Alberta Heritage Foundation for Medical Research |
| Status | Completed |
| Study type | Interventional |
| Conditions | Contrast-induced Nephropathy, Acute Renal Failure, Chronic Renal Failure |
| Intervention type | Drug |
| Interventions | intravenous saline hydration + mannitol + furosemide, intravenous saline hydration |
| Enrollment | 200 |
| Start date | May 1, 1996 |
| Primary completion | Oct 1, 2000 |
| First posted | Sep 15, 2005 |
| Last update posted | May 10, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: